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Abstract
A transgenic mouse line harbouring a b-galacdosidase reporter gene controlled by the proximal 2 kb promoter of Hoxa3
was previously generated to investigate the regulatory cues governing Hoxa3 expression in the mouse. Examination of
transgenic embryos from embryonic day (E) 8.0 to E15.5 revealed regionally restricted reporter activity in the developing
heart. Indeed, transgene expression specifically delineated cells from three distinct lineages: a subpopulation of the second
heart field contributing to outflow tract myocardium, the cardiac neural crest cells and the pharyngeal endoderm.
Manipulation of the Retinoic Acid (RA) signaling pathway showed that RA is required for correct expression of the
transgene. Therefore, this transgenic line may serve as a cardiosensor line of particular interest for further analysis of outflow
tract development.
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Introduction
Cardiac development requires specification, proliferation,
migration and differentiation of progenitor cells from diverse
tissues of the embryo [1]. Myocardial progenitor cells in the
anterior splanchnic mesoderm are destined to form the left
ventricle and contribute to the formation of the atrio-ventricular
canal and the atria. These cells characterize the first heart field
(FHF) as opposed to a population of cardiac progenitor cells
defining the second heart field (SHF) [2,3]. SHF proliferating
progenitor cells are located in the pharyngeal mesoderm lying
medial to the FHF. Initially, FHF cells, which differentiate at
embryonic day (E)7.5, form the primitive heart tube while
subsequent addition of SHF cells at both anterior and posterior
poles lead to elongation and looping of the forming heart and
contribute to right ventricular, outflow tract (OFT) and atrial
myocardium [4,5,6,7]. SHF cells express genes including Fgf8,
Foxh1, Tbx1, Isl1 and Nkx2.5 of which inactivation leads to defects
in the development of SHF progenitors and subsequently of the
OFT [5,8,9,10,11].
Neural crest cells are multipotent stem cells that originate from
the dorsal neural tube and give rise to various structures such as
nerves, ganglia, cartilages, bones and connective tissue [12,13].
Cardiac neural crest cells are a subdivision of the cranial crest
originating from the level of the otic placode to the caudal border
of somite 3, corresponding to rhombomeres 6, 7 and 8 [12,14,15].
Cells of the neural crest migrate to the third, fourth and sixth
pharyngeal arches (PA), where they are largely devoted to
glandular and vascular development. Cardiac neural crest cells
play an important role in patterning the aortic arch arteries and
form the smooth muscle tunics of the great arteries. The migration
patterns of neural crest cells in mammalian species have been
identified by fate-mapping studies with gene expression markers
for neural crest cells [16,17,18]. Thus, a subset of the cardiac
neural crest cells migrates between the aortic sac and the
pharyngeal endoderm and infiltrates the cardiac outflow cushions
[16,17,18]. Ablation and quail-chick chimera experiments showed
that cardiac neural crest cells are absolutely required to form the
aorticopulmonary septum dividing the cardiac arterial pole into
systemic and pulmonary circulations [12].
The morphogenesis of the arterial pole (outflow tract) of the
heart is a complex process that is defective in many congenital
heart defects and depends on the interaction between cardiac
neural crest and SHF cells after formation of the primitive heart
tube [12,19,20]. Indeed, addition of SHF derived cells and
migration of cardiac neural crest cells into the OFT temporally
overlap (embryonic days 9.5–10.5) [4,21]. Recent data have
suggested that a cross-talk between these two cell populations is
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cardiac neural crest results in failure of the OFT to lengthen by
addition of myocardial progenitors from the SHF [19,20]. Second,
loss of Tbx1 in pharyngeal mesoderm (SHF) can negatively impact
on cardiac neural crest cells [11]. Pharyngeal endoderm has been
implicated as a third player in development of the OFT. Indeed, a
study showed that Sonic Hedgehog produced by pharyngeal
endodermal cells has a direct or indirect action on cardiac neural
crest and SHF cells survival, respectively [22]. These data suggest
that normal OFT morphogenesis depends on an intricate interplay
between cardiac neural crest, SHF and pharyngeal endoderm.
Hox genes encode a class of transcription factors that play an
important role in patterning vertebrate axial development [24,25].
For example, the axial identity of the hindbrain neural crest is
controlled by a combinatorial pattern of Hox gene expression [26].
Among the Hox family, Hoxa3 is expressed in the hindbrain neural
tube in rhombomeres 5 and 6 [27]. The neural crest cells
populating the third pharyngeal arch originate from rhombomeres
5, 6 and 7 [28]. These cardiac neural crest cells express Hoxa3 as
does the endodermal eptithelium of the third pharyngeal pouch
[29]. In Hoxa3 null mutant embryos, the neural crest cell
population fails to induce differentiation of surrounding arch
and pouch tissues leading to abnormal development of the third
arch artery, and defects in the thymus, parathyroid gland and
carotid body [30,31]. Interestingly, a recent study has shown that
Hoxa3 is also expressed in a sub-population of SHF cells that
contributes to the OFT myocardium [32].
A classical approach to gain insight into regulatory mechanisms
controling Hox gene expression is to dissect the flanking regions
and test for activity in transgenic embryos. To document the
expression pattern provided by the proximal 2 kb of the Hoxa3
promoter in transgenic mice, we generated lacZ transgenic mice
that revealed ß-galactosidase expression in specific territories
including particular hindbrain, ganglionic and branchial compart-
ments development of which relies on Hoxa3 activity [33]. In
addition to the neural tissue, we observed ß-galactosidase
expression in the heart of the transgenic embryos. In this study,
we document the expression of this reporter transgene and show
that it is specifically expressed in three cell populations important
for OFT development. It is first activated in a subpopulation of the
SHF expressing Isl1 and later in OFT myocardial cells. Second,




th PAs at E9.5-E10.5. Third the pharyngeal
endoderm surrounding the SHF exhibits strong ß-galactosidase
expression from E8-8.5 onwards. At E10.5, high level of ß-
galactosidase expression is detected in SHF-derived myocardial
cells and cardiac neural crest cells that populate OFT cushions, as
demonstrated by co-localisation of ß-galactosidase with SHF and
cardiac neural crest cells markers. Interestingly, manipulation of
the Retinoic Acid (RA) signaling pathway using Raldh2
-/- embryos
or injection of all-trans-RA reveals that Hoxa3-lacZ expression is
sensitive to RA dosage. This transgenic line will therefore be of
particular use for further investigation of the cellular and
molecular interactions between SHF, cardiac neural crest cells
and pharyngeal endoderm.
Results
The Hoxa3-lacZ transgene is active in the pharyngeal
region and cardiac neural crest cells
The expression profile of the proximal 2 kb promoter of Hoxa3
was previously examined both in transgenic mouse line and in
transient transgenic embryos. This transgene recapitulates a subset
of the Hoxa3 gene expression in specific territories including
particular hindbrain, ganglionic and branchial compartments
development of which relies on Hoxa3 activity [33].
After four backcrosses in an outbred, CD-1 mouse genetic
background, the transgenic line derived from the construct
(H3TG3, 33) exhibited a slightly narrowed expression pattern in
whole mount stained embryos with respect to our initial record
(Figure 1). At embryonic day (E) 8.5 X-gal staining of Hoxa3-lacZ
transgenic embryos revealed detectable ß-galactosidase activity at
the dorsal midline of the neural tube, in lateral plate mesoderm, in
otic vesicles and in the pharyngeal region (Figure 1A). This pattern
was similar at later stages including E9.5 (Figure 1B), E10.5
(Figure 1C) and E11.5 (not shown). Focusing on the pharyngeal
region, ß-galactosidase activity was confined in the pharyngeal
endoderm and developing pharyngeal arches (PAs) at E8.5
(Figure 1D and not shown). By E9.5 and E10.5, whole mount
stained embryos exhibited ß-galactosidase activity in PA3, 4 and 6
(Figure 1E, F). Since pharyngeal tissue provides different cellular
progenitors crucial for outflow tract (OFT) development, we
extended our analysis of Hoxa3-lacZ transgene expression during
cardiac development.
We first stained whole transgenic hearts at different develop-
mental stages (Figure 2). ß-galactosidase activity was essentially
detected in the arterial pole (outflow tract) of E9.5 (Figure 2A),
E10.5 (Figure 2B), E12.5 (Figure 2C) and E15.5 (Figure 2D)
transgenic hearts. Since both SHF and cardiac neural crest cells
contribute to OFT development during cardiogenesis, we
investigated the nature of ß-galactosidase-positive cells in this
region. As previously reported, mesenchymal cells in the 3
rd and
4
th PAs expressed the Hoxa3-lacZ reporter at E9.5 [33] and E10.5
(Figure 3). Histological sections from E10.5 transgenic embryos
confirmed clear ß-galactosidase expression in PA3, 4 and 6
(Figure 3A) and OFT mesenchyme (Figure 3E). Of note, at E15.5,
X-gal labeled cells were found associated with vessels deriving
from these three caudal PAs (Figure 2D). These observations
suggest that X-gal labeled cells are cardiac neural crest cells. In
addition to surface ectoderm, neural crest cells including the
cardiac neural crest cell population are a prominent site of AP-2a
expression [34]. Therefore, we used AP-2a as a specific marker of
the migratory cardiac neural crest cell population that populate
PA3 to 6 and the OFT of the heart [34,35]. Immunostaining for
AP-2a on transgenic sections at E9.5 and E10.5 showed that X-gal
labeled ectodermal cells expressed AP-2a transcription factor as
expected (Figure 3B, arrowheads). In addition, ß-galactosidase–
expressing mesenchymal cells of PA3-6 also exhibited nuclear
staining for AP-2a (Figure 3B) suggesting that these cells are neural
crest-derived cells. At E10.5, the aortic sac (AS) expressed the
transgene on whole mount heart (Figure 2B, asterisk), and on
histological sections X-gal labeled cells were detected in the
pharyngeal endoderm and AS (Figure 3C). AP-2a-expressing
cardiac neural crest cells could be detected in the region between
the pharyngeal endoderm and the AS, and, in contrast to X-gal-
positive cells of the pharyngeal endoderm, ß- galactosidase–
expressing cells populating the AS were AP-2a positive (Figure 3D).
This pattern matches to that previously reported for independent
mouse neural crest lineage markers [16,35,36,37].
Expression of AP-2a is mostly extinguished by E11.5 when the
cardiac neural crest cells have migrated into the OFT of the
developing heart [35] whereas the AP-2a lineage is detected in the
OFT cushion in AP-2a-Cre; R26R mouse embryos [37]. Cardiac
neural crest cells undergo extensive cell rearrangements during the
formation of the aorticopulmonary septum in the OFT which
require N-cadherin [38]. We therefore analyzed N-cadherin
expression in wild-type and transgenic embryos at E9.5 and
E10.5 as an alternative marker of cardiac neural crest cells (Figure
A Hoxa3 Cardiosensor Transgene
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the OFT, whereas N-cadherin was already expressed in OFT,
atrial and ventricular myocardium (Figure S1A, C). At E10.5,
cardiac neural crest cells migrated into the distal end of the OFT,
as demonstrated by detection of N-cadherin in this region,
although at lower levels compared to myocardial expression
(Figure S1B, D) [38]. Immunostaining for N-cadherin on E10.5
transgenic hearts demonstrated that ß-galactosidase activity
colocalized with the N-cadherin protein in the OFT mesenchyme
(Figure 3E, F), suggesting that these transgenic cells represent
cardiac neural crest cells migrating into the OFT. In conclusion,
the Hoxa3-lacZ transgene was expressed in migratory cardiac
neural crest cells of the caudal PAs (3, 4 and 6) and in cardiac
neural crest derived mesenchymal cells that populate the cushions
in the OFT between E9.5 and E10.5, prior to formation of the
aorticopulmonary septum.
Since cardiac neural crest cells differentiate into smooth muscle
cells (SMC) during formation of the aorticopulmonary septum, we
tested whether differentiated SMC were also ß- galactosidase-
positive in the cushions (inset Figure 2B). By E11.5, reporter
activity was observed in the OFT of whole mount stained hearts
(not shown). Histological sections confirmed X-gal labeled cells in
the cushions (Figure 4A, asterisks). Immunostaining for smooth
muscle a-actin (a-SMA) demonstrated that ß-galactosidase-
positive cells in mesenchyme expressed a-SMA (Figure 4B).
Indeed, those ß- galactosidase- and a-SMA-positive cells were
negative for the marker cardiac actin (c-actin) on adjacent sections
(Figure 4C) that is normally expressed by myocardial cells that
penetrate the septum from the myocardial wall and are also a-
SMA-positive (Figure 4B, C), as previously observed [39]. By
E13.5, the aorta and pulmonary trunk contained X-gal labeled
cells (Figure 2C). On histological sections, ß- galactosidase-positive
cells were detected in the aortic and pulmonary trunks as well as in
the ductus arteriosus derived from the left 6
th aortic arch artery
(Figure 4D) and co-expressed a-SMA on adjacent sections
(Figure 4E). At E13.5, the mesenchymal outlet septum formed
by fusion of the OFT cushions exhibited ß-galactosidase activity
(Figure 4F, 4G, arrowhead). These cardiac neural crest derived
mesenchymal cells were previously demonstrated to be derived
from the AP-2a lineage [16,37]. These cushions were in the
process of extensive muscularization as revealed by c-actin staining
(Figure 4G). Scattered b- galactosidase/c-actin-double positive
cells were observed in the aortic trunk but not in the ductus
arteriosus where ß-galactosidase-positive cells were not stained for
c-actin (Figure 4G). Together, the pattern of transgene expression
in the PAs and arterial pole of the heart recapitulated a subset of
the cardiac neural crest migratory route [16,18,35,37].
Expression of the transgene in a subdomain of the SHF
and OFT myocardium
SHF progenitor cells are characterized by the expression of Isl1
[5], Nkx2.5 [9], Fgf8, Fgf10 [4], and Tbx1 [11], and cells that have
transcribed these genes form the arterial pole of the heart. The
Mef2C SHF enhancer (Mef2c-AHF-lacZ) [40] and the Mlc1v-nlacZ-
24 transgene [4] are also expressed in the SHF. Cell tracing and
explant culture experiments have shown that SHF progenitor cells
contribute to the inflow and outflow tracts [4,5,6,7]. As mentioned
above, Hoxa3-lacZ transgenic embryos exhibited X-gal staining in
the forming posterior PAs and pharyngeal endoderm at E8.5
(Figure 1D, arrowhead). At E9.5, on whole mount stained heart,
transgene expression was detected in the distal region of the OFT
(Figure 2A). Histological sections showed that X-gal-labeled cells
Figure 1. Time course of Hoxa3-lacZ transgene activity at early embryonic stages. (A, B, C) Lateral view of E8.5 (A), E9.5 (B) and E10.5 (C)
transgenic embryos stained for lacZ activity and corresponding magnification of the pharyngeal and heart region, (D, E and F, respectively).
Arrowheads in A and B indicate the lateral plate mesoderm; the arrowhead in D shows the pharyngeal endoderm; the arrow in F indicates the
pharyngeal mesoderm lying caudally to the OFT. Asterisks in A-to-C indicate the otic vesicle. Numbering 1, 2, 3, 4 and 6 indicates the pharyngeal
arches. FL; forelimb; Ht, heart; HL, hindlimb. Scale bar=100 mm.
doi:10.1371/journal.pone.0027624.g001
A Hoxa3 Cardiosensor Transgene
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pharyngeal endoderm cells displayed broad X-gal staining (Figure
S1G). Between E10 and E10.5, we observed increased X-gal
staining in the OFT (Figure 2B) as well as in pharyngeal mesoderm
caudal to this region (Figure 1F, arrow). Sections confirmed
reporter activity in OFT myocardium (Figure 5A, B) as well as in a
sub-region of the SHF (Figure 5B). To better characterize the
identity of the X-gal labeled cells in the SHF and OFT
myocardium, we performed immunostaining for Isl1 protein and
c-actin, as a marker of differentiated cardiomyocytes, in E9.5 and
E10.5 transgenic embryos. Isl1 protein is used as a pan-marker of
SHF cells as well as cardiomyocytes of the distal OFT [9,41].
Results showed that X-gal labeled cells were either single positive
for Isl1 or double Isl1/c-actin positive (Figure 5C-F, and Figure
S1H). Taken together, these results showed that the transgene is
expressed in the anterior SHF, in differentiating as well as recently
differentiated cardiomyocytes of the distal portion of the OFT.
The changing position of X-gal labeled cells during OFT
formation therefore provided a ‘‘chase’’, marking cells which
previously transcribed the Hoxa3-lacZ transgene. Similarly, in
Mef2C-AHF-lacZ [40] and Mlc1v-nlacZ-24 [4] transgenic embryos,
ß-galactosidase expression were more extended in the SHF and
included the OFT and right ventricle at E8.5 and E9.5 (see below,
Discussion). In accordance with restricted staining of the SHF by
Hoxa3-lacZ cells, the inflow tract, atria and right ventricle were
negative for ß-galactosidase activity between E9.5 and E15.5.
Therefore, at E10.5, the Hoxa3-lacZ transgene is activated in
both cardiac neural crest and SHF-derived myocardial cells at a
crucial time of OFT development.
Hoxa3- lacZ activity is sensitive to Retinoic Acid signaling
Retinoic Acid (RA) is the active derivative of vitamin A that
plays crucial roles in various steps of cardiovascular development
[42,43]. In addition, a recent study has shown that expression of
Hoxa3 in a sub-population of SHF cells depends on RA signaling
[32]. We therefore analyzed the responsiveness of Hoxa3-lacZ
transgene to changes in RA signaling in transgenic embryos.
To visualize the Hoxa3-lacZ expression pattern in the absence of
RA signaling, we generated embryos harboring the Hoxa3-lacZ
transgene but deficient for retinaldehyde dehydrogenase 2
(Raldh2
2/2), the enzyme that catalyzes the second oxidative step
inRAbiosynthesis[44].Aspreviouslyreported,Raldh2
2/2embryos
failed to undergo heart looping and have impaired atrial and sinus
venous development compared to wild-type hearts [45] (Figure 6A,
B). In contrast to wild-type Hoxa3-lacZ transgenics, Raldh2
2/2;Hoxa3-
lacZ embryos lacked ß-galactosidase activity in the entire embryo
except for faint staining in the pharyngeal region at E8.5 (compare
Figure 6A and 6B) and E9.5 (Figure 6C, D). Hoxa3-lacZ expression
was thus abrogated under RA deficiency showing that transgene-
expressing cells are regulated by RA signaling.
Because cardiac patterning is sensitive to administration of
exogenous RA at early stage (E6.75–E8.5) [46,47,48,49], we have
also examined the effect of exogenous RA on transgene expression
in the embryo at a stage when cardiac neural crest and SHF cells
are responsive to RA [46,47,48,49]. In contrast to Hoxa3-lacZ
control E7.5 embryos treated with vehicle only (Figure 6E), those
treated with exogenous RA exhibited an up-regulation of Hoxa3-
lacZ in the heart field at E8 (Figure 6F, G), confirming that the
transgene is sensitive to an increase in RA dosage.
Discussion
In this study, we characterize transgenic embryos harboring a
reportertransgenecontrolledbytheproximal2 kboftheHoxa3gene
promoter that is expressed in several tissues required for OFT
development and depends on the RA signaling pathway. Using X-
gal staining and immunostaining for markers of distinct cardiac
lineages, we demonstrated that the transgene exhibited b-galacto-
sidaseactivityinthePAsandtheOFT duringcardiogenesis.General
feature of our analysis may be relevant to the tripartite interactions
between cardiac neural crest, SHF and pharyngeal endodermal cells
during cardiac development in general and OFT morphogenesis in
particular. First, the transgene is expressed in the pharyngeal
endoderm from E8.5 to E11.5. Second, the transgene is activated in
the migratory cardiac neural crest cells of the PAs and those that
populate the OFT and participate in its septation. Third, a sub-
domainof SHF progenitor cells expressed the transgene at E9.5and,
most importantly, at E10.5, SHF-derived cells in the OFT further
displayed transgene expression. Finally, we observed that transgene
activity is lost in Raldh2
2/2 mutant embryos while it is precociously
and highly up-regulated in all-trans-RA treated embryos.
Hoxa3-lacZ expression in cardiac neural crest cells, SHF
and OFT myocardium
Our study showed Hoxa3-lacZ expression in migratory cardiac
neural crest cells that invade the 3
rd,4
th and 6
th PAs [28], OFT,
Figure 2. Expression of the Hoxa3-lacZ transgene during
cardiogenesis. Ventral views of whole mount hearts X-gal stained at
E9.5 (A), E10.5 (B), E13.5 (C) and E15.5 (D). (A) X-gal stained cells are
present in the inferior and superior walls of the distal OFT (arrowheads),
and in the aortic sac indicated by the asterick. (B) ß-gal activity is
extended in the proximal OFT and clearly visible in the aortic sac but
still excluded from atria and ventricles (arrowheads indicate the
transverse section level corresponding to the image inset). (C) Labeled
cells are detected in the aortic and pulmonary trunk at E12.5. (D). At
E15.5 X-gal staining in the aorta and pulmonary trunk includes the
myocardium at the base of these vessels. At all these stages Hoxa3-lacZ
is silent in the atria and ventricles (A–D). Ao, aorta; IA, innominate artery;
LA, left atrium; LCA, left common artery; LSA left subclavian artery, LV,
left ventricle; OFT, outflow tract; PT, pulmonary trunk; RA, right atrium;
RCA, right common artery; RSA, rigth subclavian artery;RV, right
ventricle. Scale bars=100 mm.
doi:10.1371/journal.pone.0027624.g002
A Hoxa3 Cardiosensor Transgene
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th aortic arch arteries. In all these territories, ß-galactosidase
activity colocalised with cardiac neural crest markers such as AP-
2a and N-cadherin. Interestingly, the expression pattern of Hoxa3-
lacZ in the cardiovascular system partially recapitulated that
previously reported for transgenic lines expressing lacZ in cardiac
neural crest under the control of the proximal 650-bp of the
Connexin43 gene promoter [18] as well as of those obtained upon
Cre/lox-mediated induction involving the neural crest specific
Pax3, Wnt1 or human tissue plasminogen activator (Ht-PA)
promoters [16,17,18,50]. Our results are consistent with previous
studies showing that Hoxa3 expression is detected in the neural




Moreover, in Hoxa3 mutant embryos the third arch arteries
degenerate [30,31].
In addition to being expressed in the cardiac neural crest that
populate the OFT, the Hoxa3-lacZ reporter is also active in a sub-
domain of the SHF and myocardial cells of the OFT. This
expression pattern in SHF progenitors and SHF derived-
myocardial cells is in sharp contrast with other previously
described SHF reporter lines [4,5,40]. Indeed, the Mlc1v-nlacZ-
24 and Mef2C-AHF-lacZ reporter transgenes both mark a larger
portion of the SHF, and subsequently identify cells that are found
in both OFT and right ventricular myocardium [4,7,40]. The
labeling of these progenitor cells occurred essentially at the time
(i.e. E7.5) of anatomic appearance of the SHF [4,40]. Conversely,
Hoxa3-lacZ expression was delayed by 24h since Hoxa3-lacZ
positive cells were detectable by E8.5 and only in a sub-domain
of the SHF. Thus, it only partially overlaps with that of the Mef2C-
AHF-lacZ or Mlc1v-nlacZ-24 lines (Figure 7). However by E10.5,
Hoxa3-lacZ transgene expression was extended in the SHF and
Figure 3. lacZ-positive cells in the pharyngeal arches, aortic sac and OFT identify migratory neural crest cells. Sagittal sections of E10.5
transgenic embryos at the level of the 3
rd,4
th and 6
th pharyngeal arches (A, B), aortic sac (C, D), and outflow tract (E, F). Ap2a (B, D) and N-cadherin (F)
immunochemistry on X-gal-stained adjacent sections demonstrates that lacZ-positive cells in the pharyngeal arches (B) as well as those populating
the space between the pharyngeal endoderm and aortic sac (D) and outflow tract mesenchyme (F) are cardiac neural crest cells. Arrowheads and
arrows (B) indicate the pharyngeal ectoderm and AP2
+ LacZ
+ cells in pharyngeal arches ectoderm and mesoderm, respectively. Arrows and
arrowheads (C, D) show the pharyngeal endoderm and AP2
+ LacZ




th pharyngeal arches, respectively. Scale bars=100 mm.
doi:10.1371/journal.pone.0027624.g003
A Hoxa3 Cardiosensor Transgene
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nlacZ-24 transgene activities, except for its exclusion from the right
ventricle (Figure 7). Thus, in our transgenic model, the initial SHF
progenitors deployed to the heart tube at both poles to generate
myocardial cells of the atria and right ventricle are negative for
Hoxa3-lacZ (Figure 7). Subsequently (i.e. at E10-10.5) the entire
OFT myocardium (also labeled by Mlc1v-nlacZ-24 and Mefc2C-
AHF-lacZ) expresses Hoxa3-lacZ concurrently with cardiac neural
crest cells populating the OFT. This cardiac neural crest
contribution would bring cells needed in the OFT to interact
with the underlying myocardium for correct OFT development at
E9.5–10.5 [16]. It has been reported that the presence of cardiac
neural crest cells in the caudal pharynx is crucial for the addition
of SHF to the OFT myocardium [19,20,52,53], but to date, no
gene and/or reporter transgene were reported to be expressed in
the underlying pharyngeal endoderm, cardiac neural crest cells
and SHF–derived myocardium during OFT development. For the
first time here, we describe a transgenic line (Hoxa3-lacZ) which
therefore appears attractive to investigate potential ‘‘tripartite’’
interactions between these cell populations crucial for OFT
development.
The Mlc1v-nlacZ-24 and Mef2C-AHF-lacZ transgenes show bona
fide expression patterns with respect to the Fgf10 and Mef2C
enhancer elements from which they are derived respectively
[4,40]. A recent study shows Hoxa3 expression in a sub-population
of SHF cells that contribute to OFT myocardium [32]. Thus, the
Hoxa3-lacZ transgene is likely to reflect a specific activity of Hoxa3
in SHF cells.
Hoxa3-lacZ and RA signaling
Several lines of evidence show that the expression of some Hox
genes from paralogous group 1 is dependent on RA signaling
[54,55]. Moreover, the study by Bertrand et al. (2011)[32] shows
that Hoxa3 expression in the SHF is dependent on RA signaling.
Here, we showed that RA deficiency negatively affected the
Hoxa3-lacZ in all the territories in which it is active including the
PAs, OFT and pharyngeal endoderm whereas exogenous RA
induced its precocious activation and further enhanced its activity
in cardiac progenitors. These data therefore demonstrate that
Hoxa3-lacZ is sensitive to RA dosage. The Hoxa3-lacZ transgene
was made up of the proximal 2 kb of the Hoxa3 gene promoter
[33]. Careful sequence analysis allowed predicting a highly
conserved DR5-RARE element, which could mediate this RA
responsiveness (Figure S2). Alternatively, it may be possible that
this Hoxa3 promoter region is indirectly regulated by RA signaling
via an RA sensitive Hoxa3 transcriptional modulator.
RA deficiency alters gene expression in the SHF and induces a
posterior expansion of markers of the SHF, including Tbx1, Fgf8,
Islet1 and the Mlc1v-nlacZ-24 reporter transgene [48,49]. This is in
sharp contrast with the results reported here for Hoxa3-
Figure 4. Distribution of X-gal-labeled cells in transgenic hearts before (E11.5) and after (E13.5) outflow tract septation. Transverse
sections of E11.5 (A-C), and E13.5 (D-G) developing hearts (A) X-gal-labeled cells are present in the cushion of E11.5 embryos (asterisks) and (B) on
adjacent section, a-SMA staining shows that lacZ-expressing cells correspond to cardiac neural crest differentiating into smooth muscle that (C) are
negative for c-actin expression and are thus not muscularized. Arrowheads in C indicate myocardial spikes protruding toward the cushion
mesenchyme. (D) X-gal stained cells are detected in the aortic and pulmonary trunk as well as in the ductus arteriosus (arrowhead). (E) These lacZ-
positive cells also express a-SMA. (F) At E13.5, the outlet septum stains positive for X-gal (arrowhead). (G) c-actin immunostaining demonstrates that
myocardialization occurs in this region as well as in the cushion at base of the aorta. Ao, aorta; DAo, dorsal aorta; LA, left atrium; OFT, outflow tract;
Ot, outlet; PT, pulmonary trunk; RA, right atrium; RV, right ventricle; Tr, Trachea. Scale bars=100 mm.
doi:10.1371/journal.pone.0027624.g004
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-/- embryos. However, the sensitivity of the transgene to
RA is consistent with the down regulation of Hoxa3 reported in the
hindbrain and pharyngeal region of Raldh2
2/2 embryos [56]. A
recent report on the fate of RA–activated embryonic cell lineages
revealed that among many tissues, migratory cardiac neural crest
cells of PA3 to 6, pharyngeal endoderm, atrial chamber, OFT,
aortic arches, and dorsal aorta are responsive to RA signaling [57].
Hence, the loss of Hoxa3-lacZ transgene expression in Raldh2
2/2
embryos at E8.5 and E9.5 may result from cell death and/or
failure in the development of cardiac neural crest cells fated to
populate PA 3, 4 and 6. Indeed, increased apoptosis was observed
in the hindbrain and neural crest cells of Raldh2
2/2 embryos [56],
and a loss of X-gal staining in these tissues was reported at E8.5
and E9 in Raldh2
2/2 embryos harbouring RARE-Cre and R26R
transgenes [57].
Hoxa3 expression has been reported to be altered in RA-exposed
embryos [58,59]. Indeed, RA-exposed embryos exhibited preco-
cious and increased Hoxa3 expression within its normal expression
domain and expression in the hindbrain was shifted rostrally.
Among the developmental defects reported in these RA-treated
fetuses, transposition of the great arteries or stenosis of the carotid
artery, interrupted aortic arch, double outlet right ventricle,
truncus arteriosus with a high ventral septal defect and insertion of
the internal and external left carotid arteries directly in the aortic
arch, were reported [58]. These defects are reminiscent of those
observed in several genetic models of congenital heart diseases
affecting SHF progenitors and cardiac neural crest cell develop-
ment [22,23]. The precocious or ectopic activation of Hoxa3 in
RA-treated embryos may reflect the way changes in the
combinatorial Hox code affect cardiac development
[32,58,60,61]. RA may thus act as a global morphogen involved
in coordinated Hox gene expression in cardiac progenitor cells, as
it does for embryo axial structures.
Conclusion
We have described a mouse reporter transgene which delineates
three crucial cell lineages for the OFT development. In contrast to
the cardiosensor lines reported until now, this Hoxa3-lacZ reporter
Figure 5. b-gal, Islet-1 and cardiac actin expression in the hearts of transgenic embryos at E9.5 and E10.5. Transverse (A, C, E) and
sagittal (B, D, F) sections of E9.5 and E10.5 transgenic embryos, respectively. (A) The X-gal-stained cells in the outer layer of the outflow tract also
express Isl1 (C, arrowheads). Only transgenic cells in the distal outflow tract (delineated by arrowheads in A) express c-actin (E, arrowheads). Note that
dorsal part of the developing aortic sac (asterisk in A) is filled with Isl1-expressing cells. (B) X-gal-stained cells are present in the outflow tract region
and anterior portion of SHF demarcated by the red arrowheads. (D) Isl1-immunostained cells are present in this anterior portion of SHF (demarcated
by the red arrowheads) and outflow myocardium, whereas c-actin is restricted to myocardial transgenic cells of the outflow tract (F, arrowheads). OFT,
outflow tract. Black and white asterisks in (A) and (B) show the aortic sac and pharyngeal endoderm, respectively. Scale bars=100 mm.
doi:10.1371/journal.pone.0027624.g005
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derived OFT myocardium and pharyngeal endoderm at the
period of OFT morphogenesis. The other reported lines mark
either cardiac neural crest cells [16,17,18,50,62] or the OFT
myocardium [4,40] but not both cell populations. This line
appears as an alternative tool for further studies of interactions
between cardiac neural crest cells, OFT myocardial cells and
pharyngeal endoderm in specific genetic systems and for
understanding the etiology of congenital heart defect.
Materials and Methods
Ethics statement
All animal work has been conducted according to relevant
national and international guidelines and approved by the
‘‘Comite ´ d’e ´thique pour l’expe ´rimentation animale, Universite ´
catholique de Louvain, Louvain-la-Neuve’’ (approval number #
053001).
Mouse lines
The reporter transgene we generated, referred to as Hoxa3-lacZ,
consists of the Escherichia coli lacZ gene fused to a 2-kb fragment of
the Hoxa3 promoter extending up to the ATG codon of the Hoxa3
reading frame (Figure S2). The detailed transgene construction
and mouse transgenesis have been described previously [33].
The Raldh2 mutant line was described by Niederreither et al.
(1999)[44]. To assess the expression Hoxa3-lacZ in Retinoic Acid
deficient background, males hemizygote for Hoxa3-lacZ and
heterozygote for Raldh2 (Hoxa3-lacZ; Raldh2
2/+) were crossed with
heterozygote female Raldh2
2/+ to generate E8.5 and E9.5 Hoxa3-
lacZ; Raldh2
2/2 embryos.
X-gal staining and immunohistochemistry
To document the expression pattern of the reporter, embryos
from E7.5 until E17.5 were analysed both morphologically (whole
mount stained) and histologically. At least three transgenic embryos
of each stage were analysed according to Theiler’s nomenclature.
For lacZ staining, embryos obtained between E7.5 and E17.5 were
fixed in 4% paraformaldehyde for 30 to 90 min at 4uC. They were
then washed twice in 1% phosphate buffer saline (PBS) at room
temperature for 20 min and stained overnight at 30uC in 40 mg/ml
X-gal, 200 mM K3Fe(CN)6, 200 mM K4Fe(CN)6, 1M MgCl2,
1xPBS.Forhistologicalanalyses,embryostobesectionedwerefixed
overnight in 4% paraformaldehyde at 4uC, stained as above,
dehydrated and embedded in paraffin (or stored in 70% ethanol
until use). 6–to-8 mm thick sections were counterstained with eosin.
For immunohistochemistry, sections from E9.5–13.5 dissected
embryos were deparafinized in xylene, rehydrated and finally
washed in 1xPBS. Following antigen retrieval in 10 mM citric acid
(pH 6.0), sections were blocked with 5% goat serum in 1xPBS for
1 hour at room temperature and then incubated with various
primary antibodies. Endogenous peroxidases samples were
inhibited with 3% H2O2 in water for 10–15 min and washed in
1xPBS. For the detection of cardiac actin (c-actin), Islet-1, N-
cadherin, AP-2a, PECAM-1 and a-smooth muscle actin (a-SMA)
expression, the following antibodies were diluted in a solution of
0.1% Triton X-100/5% goat serum/PBS and used at 4uC O/N at
the dilutions shown: anti-mouse c-actin (1:400, A2547 Sigma),
anti-rat N-cadherin (1:400, DSHB clone MND2) and anti-mouse
Isl1 (1:100, DSHB, clone 39.4D5), AP-2a (1/100, DSHB clone
3B5) and mouse anti a-SMA (clone 1A sigma, 1/1000). The
primary antibodies were detected with biotinylated second
antibody goat anti-rat, goat anti-mouse, or goat-anti-rabbit
(1:200, Vector Laboratories) followed by avidin-biotin binding
(Vectastatin ABC kit, Vector Laboratories) and application of 3,39-
diaminobenzidene (Vector Laboratories). After desired color
intensity was achieved, reaction was stopped by extensive wash
in distilled water. The samples were then dehydrated through
increasing ethanol (70%, 95% and 100%), immersed in xylene and
mounted in DEPEX (EMS).
For immunofluorescence, sections were treated with sodium
borohydride (1 mg/ml) on ice to eliminate the epifluorescence due
to fixative, and blocked in a solution of 0.1% Triton X-100/5%
donkey serum/1xPBS. The following antibodies were used at the
dilutions shown: c-actin (mouse, 1:200, A2547 Sigma), anti-Islet-1
(mouse, 1: 100, DSHB), anti-N-cadherin, (rat, 1:50, DSHB).
Following overnight incubation at 4uC and washes in 1xPBS,
fluorescently labeled second antibodies (Molecular Probes) were
used at a 1:250 dilution to detect primary antibodies: 555-
conjugated donkey anti-mouse for c-actin, Alexa 488-conjugated
donkey anti-rat for N-cadherin. Sections were washed in PBS,
mounted in Prolong with DAPI (Invitrogen) and imaged on a
fluorescent microscope for analysis.
Retinoic Acid Treatment of Embryos
Retinoic Acid treatment of embryos was done as previously
described by Ryckebusch et al. (2008)[48]. All-trans-RA (Sigma)
Figure 6. RA signaling affects Hoxa3-lacZ expression in
transgenic embryos. Lateral views of E8.5 (A, B), E9.5 (C, D), and
frontal views of E8 (E,F,G) embryos. In contrast to control Hoxa3-lacZ
embryos (A, C), ß-galactosidase activity is lost in Hoxa3-lacZ/ Raldh22/2
embryos (B, D). Hoxa3–lacZ embryos treated with vehicle (DMSO) show
no activation of the transgene (E) whereas RA-treated transgenic
embryos display a precocious ß-galactosidase upregulation in the SHF
(F, G, arrowheads). Arrows (F, G) indicate the cardiac crescent. Asterisk
indicates the otic vesicle. HT, heart tube. Scale bars=100 mm.
doi:10.1371/journal.pone.0027624.g006
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Hoxa3-lacZ transgenic mice were given a single intra peritoneal
injection of the RA solution (65 mg/kg) or control DMSO.
Control and treated embryos were harvested at E7.5, E8 and E8.5
and stained for b-galactosidase activity as described above.
Supporting Information
Figure S1 Cardiac expression of N-cadherin, cardiac
Actin and Islet-1 at E9.5 and E10.5. Expression of N-
cadherin in the heart of E9.5 (A) and 10.5 (B) transgenic embryos,
with corresponding magnification of the outflow tract region (C
and D, respectively). Cardiac neural crest cells lack N-cadherin
expression at E9.5 (arrowhead in C), while it is upregulated at
E10.5 (arrowheads in D). (E) At E9.5, cardiac actin is excluded
from SHF progenitor cells (arrowheads). Arrowhead in (F)
indicates the posterior limit of differentiated cells positive for c-
actin in the outflow tract at E10.5. (G) lacZ expressing cells are
present in the pharyngeal endoderm (arrow) and in a region that
expresses Isl1 (H, arrowheads) in addition to the pharyngeal
endoderm and outflow tract proper at E9.5. OFT, outflow tract;
PE, pharyngeal endoderm; RA, right atria; RV, rigth ventricle.
Scale bar=100 mm.
(TIF)
Figure 7. Schematic view of lacZ expression pattern in of Mlc1v-nlacZ24, Hoxa3-lacZ and Wnt1Cre:R26R cardiosensor lines. Mlc1v-
nlacZ24 (A, D, G), Hoxa3-lacZ (B, E, H) and Wnt1Cre:R26R (C, F, I). At E8.5 Mlc1v-nlacZ-24 are activated in the second heart field, developing OFT
and heart tube (A), while Hoxa3-lacZ is activated in PE and barely detected in the SHF (B). At this stage the heart is devoid of migrating cardiac neural
crest cells (C). At E9.5 the SHF progenitors, OFT and RV myocardium are labeled in Mlc1v-nlacZ-24 (D). The PE, CNC (dots in the caudal pharynx) and a
subdomain of the SHF express Hoxa3-lacZ (E). Cardiac neural crest cells are also labeled in Wnt1cre;R26R bigenic embryos at E9.5 (F). At E10.5, Mlc1v-
nlacZ-24 transgenic hearts identify SHF, OFT and RV (G). In addition to the anterior portion of SHF and PE, Hoxa3-lacZ transgene activity identifies
cardiac neural crest and myocardial cells of the OFT, whereas the RV remains negative for lacZ staining (E). Cardiac neural crest cells similarly invades
the OFT in Wnt1cre;R26R bigenic embryos at E10.5 (I). Hoxa3-lacZ clearly appears as an intermediary reporter line that display hybrid expression
pattern reminiscent to that of Mlc1v-nlacZ24 and Wnt1cre;R26R bigenic. Blue and pink colors indicate lacZ-positive and -negative cells, respectively.
Black and red arrowheads designate the pharyngeal endoderm (PE) and second heart field (SHF), respectively. A, atria; HT, heart tube; Oft, outflow
tract; RA, right atria; RV, rigth ventricle.
doi:10.1371/journal.pone.0027624.g007
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kb promoter of Hoxa3 used to generate the Hoxa3-lacZ
reporter transgene. The Asp718-NruI 2-kb genomic fragment
from the mouse Hoxa3 locus was fused to the E. coli lacZ coding
sequence to generate the reporter transgene. The sequence of the
59 moiety of the promoter is shown and contains a predicted DR5
RARE site (underlined bold italics). Asp718 and XbaI restriction
sites are shown in bold case.
(TIF)
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